Becton, Dickinson and Company
BDXBecton, Dickinson and Company (BDX) is a Healthcare company that currently yields 2.46% — historically undervalued based on 10 years of dividend yield history. The Weiss valuation model places the undervaluation threshold at $175.15 and the overvaluation threshold at $267.59. Becton, Dickinson and Company holds a quality score of 62/100 (Good), reflecting 9 consecutive years of dividend growth with a 73% payout ratio. The 5-year dividend CAGR stands at 6.0%.
BDX Dividend Yield History — Weiss Valuation
Why Now?
Becton, Dickinson and Company is trading near its historical undervaluation band.
Current yield 2.5% vs historical max 2.0% (123% of maximum).
9 years of uninterrupted dividends.
Reasonable payout ratio of 73%.
BDX Dividend Income Projection — DRIP Compounder
Dividend Compounder (DRIP)
Year 1 Income
$261
Year 10 Income
$591
Yield on Cost
6.17%
Total Income
$4,016
Assumes dividends reinvested at current price. Simplified model — for illustrative purposes only.
BDX Dividend Quality Score
Quality Score
Good
Key Metrics
In-depth analysis
→ BDX Dividend Analysis ArticleRelated Reading
Collections